| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From MRC Clinical Sciences Centre and Division of Neuroscience (P.E., A.H., N.P., Y.F.T., G.H., A.K., M.R., D.J.B.), Hammersmith Hospital, Imperial College London; Dementia Research Centre (H.A.A., D.C., N.F., M.R.), UCL, Institute of Neurology; and Hammersmith Imanet (R.H., D.J.B.), GE Healthcare, UK.
* To whom correspondence should be addressed. E-mail: david.brooks{at}csc.mrc.ac.uk.
Abstract-- Objective: To investigate the association between brain amyloid load in Alzheimer disease (AD) measured by [11C]PIB-PET, regional cerebral glucose metabolism (rCMRGlc) measured by [18F]FDG-PET, and cognition. Methods: Nineteen subjects with AD and 14 controls had [11C]PIB-PET and underwent a battery of psychometric tests. Twelve of those subjects with AD and eight controls had [18F]FDG-PET. Parametric images of [11C]PIB binding and rCMRGlc were interrogated with a region-of-interest atlas and statistical parametric mapping. [11C]PIB binding and rCMRGlc were correlated with scores on psychometric tests. Results: AD subjects showed twofold increases in mean [11C]PIB binding in cingulate, frontal, temporal, parietal, and occipital cortical areas. Higher cortical amyloid load correlated with lower scores on facial and word recognition tests. Two patients fulfilling the clinical criteria for AD had normal [11C]PIB at baseline. Over 20 months this remained normal in one but increased in the cingulate of the other. Mean levels of temporal and parietal rCMRGlc were reduced by 20% in AD and these correlated with mini mental scores, immediate recall, and recognition memory test for words. Higher [11C]PIB uptake correlated with lower rCMRGlc in temporal and parietal cortices. Conclusion: [11C]PIB-PET detected an increased amyloid plaque load in 89% of patients with clinically probable Alzheimer disease (AD). The high frontal amyloid load detected by [11C]PIB-PET in AD in the face of spared glucose metabolism is of interest and suggests that amyloid plaque formation may not be directly responsible for neuronal dysfunction in this disorder.
This article has been cited by other articles:
|
|
 |
|
  A. D. Cohen, J. C. Price, L. A. Weissfeld, J. James, B. L. Rosario, W. Bi, R. D. Nebes, J. A. Saxton, B. E. Snitz, H. A. Aizenstein, et al. Basal Cerebral Metabolism May Modulate the Cognitive Effects of A{beta} in Mild Cognitive Impairment: An Example of Brain Reserve J. Neurosci., November 25, 2009; 29(47): 14770 - 14778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Jagust, S. M. Landau, L. M. Shaw, J. Q. Trojanowski, R. A. Koeppe, E. M. Reiman, N. L. Foster, R. C. Petersen, M. W. Weiner, J. C. Price, et al. Relationships between biomarkers in aging and dementia Neurology, October 13, 2009; 73(15): 1193 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Nagren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study Neurology, September 8, 2009; 73(10): 754 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nelissen, K. Van Laere, L. Thurfjell, R. Owenius, M. Vandenbulcke, M. Koole, G. Bormans, D. J. Brooks, and R. Vandenberghe Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease J. Nucl. Med., August 1, 2009; 50(8): 1251 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Jack Jr, V. J. Lowe, S. D. Weigand, H. J. Wiste, M. L. Senjem, D. S. Knopman, M. M. Shiung, J. L. Gunter, B. F. Boeve, B. J. Kemp, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease Brain, May 1, 2009; 132(5): 1355 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Frisoni, M. Lorenzi, A. Caroli, N. Kemppainen, K. Nagren, and J. O. Rinne In vivo mapping of amyloid toxicity in Alzheimer disease Neurology, April 28, 2009; 72(17): 1504 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. McNamee, S.-H. Yee, J. C. Price, W. E. Klunk, B. Rosario, L. Weissfeld, S. Ziolko, M. Berginc, B. Lopresti, S. DeKosky, et al. Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements J. Nucl. Med., March 1, 2009; 50(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Dai, O. L. Lopez, O. T. Carmichael, J. T. Becker, L. H. Kuller, and H. M. Gach Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR Imaging Radiology, March 1, 2009; 250(3): 856 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Fodero-Tavoletti, C. C. Rowe, C. A. McLean, L. Leone, Q.-X. Li, C. L. Masters, R. Cappai, and V. L. Villemagne Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias J. Nucl. Med., February 1, 2009; 50(2): 198 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tolboom, M. Yaqub, W. M. van der Flier, R. Boellaard, G. Luurtsema, A. D. Windhorst, F. Barkhof, P. Scheltens, A. A. Lammertsma, and B. N.M. van Berckel Detection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET J. Nucl. Med., February 1, 2009; 50(2): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Okello, P. Edison, H. A. Archer, F. E. Turkheimer, J. Kennedy, R. Bullock, Z. Walker, A. Kennedy, N. Fox, M. Rossor, et al. Microglial activation and amyloid deposition in mild cognitive impairment: A PET study Neurology, January 6, 2009; 72(1): 56 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Edison, C C Rowe, J O Rinne, S Ng, I Ahmed, N Kemppainen, V L Villemagne, G O'Keefe, K Nagren, K R Chaudhury, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography J. Neurol. Neurosurg. Psychiatry, December 1, 2008; 79(12): 1331 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Gomperts, D. M. Rentz, E. Moran, J. A. Becker, J. J. Locascio, W. E. Klunk, C. A. Mathis, D. R. Elmaleh, T. Shoup, A. J. Fischman, et al. Imaging amyloid deposition in Lewy body diseases Neurology, September 16, 2008; 71(12): 903 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sojkova, L. Beason-Held, Y. Zhou, Y. An, M. A. Kraut, W. Ye, L. Ferrucci, C. A. Mathis, W. E. Klunk, D. F. Wong, et al. Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern? J. Nucl. Med., September 1, 2008; 49(9): 1465 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Koivunen, A. Verkkoniemi, S. Aalto, A. Paetau, J.-P. Ahonen, M. Viitanen, K. Nagren, J. Rokka, M. Haaparanta, H. Kalimo, et al. PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease Brain, July 1, 2008; 131(7): 1845 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.M. Fjell, K.B. Walhovd, I. Amlien, A. Bjornerud, I. Reinvang, L. Gjerstad, T. Cappelen, F. Willoch, P. Due-Tonnessen, R. Grambaite, et al. Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Carlson, M. M. Moore, A. Dame, D. Howieson, L. C. Silbert, J. F. Quinn, and J. A. Kaye Trajectories of brain loss in aging and the development of cognitive impairment Neurology, March 11, 2008; 70(11): 828 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jack Jr, V. J. Lowe, M. L. Senjem, S. D. Weigand, B. J. Kemp, M. M. Shiung, D. S. Knopman, B. F. Boeve, W. E. Klunk, C. A. Mathis, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain, March 1, 2008; 131(3): 665 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.D. Rabinovici, W.W. Seeley, E.J. Kim, M.L. Gorno-Tempini, K. Rascovsky, T.A. Pagliaro, S.C. Allison, C. Halabi, J.H. Kramer, J.K. Johnson, et al. Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 474 - 488. [Abstract] [PDF]
|
|
|
|
 |
|
 K HERHOLZ, S F CARTER, and M JONES Positron emission tomography imaging in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S160 - S167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Pike, G. Savage, V. L. Villemagne, S. Ng, S. A. Moss, P. Maruff, C. A. Mathis, W. E. Klunk, C. L. Masters, and C. C. Rowe {beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease Brain, November 1, 2007; 130(11): 2837 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lockhart, J.R. Lamb, T. Osredkar, L.I. Sue, J.N. Joyce, L. Ye, V. Libri, D. Leppert, and T.G. Beach PIB is a non-specific imaging marker of amyloid-beta (A{beta}) peptide-related cerebral amyloidosis Brain, October 1, 2007; 130(10): 2607 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nelissen, M. Vandenbulcke, K. Fannes, A. Verbruggen, R. Peeters, P. Dupont, K. Van Laere, G. Bormans, and R. Vandenberghe A{beta} amyloid deposition in the language system and how the brain responds Brain, August 1, 2007; 130(8): 2055 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Imaging Amyloid and Regional Cerebral Glucose Metabolism in Alzheimer Disease Journal Watch Neurology, June 19, 2007; 2007(619): 1 - 1. [Full Text]
|
|
|
|
|
|
R. J. Bateman and D. Eidelberg Testing a test for Alzheimer disease Neurology, February 13, 2007; 68(7): 482 - 483. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
